APM News and Press, Aptorum Group Limited From 07/12/21

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical-stage biopharmaceutical company, announces further positive results of its ongoing Phase 1 clinical trial for ALS-4 (a first in-class anti...

Regulatory News: Aptorum Group Limited (Nasdaq: APM , Euronext Paris: APM ), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, today announced an interview with President and Executive Direc...

Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) (“Aptorum Group”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, today announced that Mr. Ian Huen, Fo...

These Hot Penny Stocks Continue to Spike As a Result of Reddit Traders Reddit penny stocks have become some of the hottest trending penny stocks to watch over the last year. If you’re unfamiliar, Reddit is a social media platform that allows individuals to form groups or Subr...

Gainers: Scopus BioPharma (SCPS) +97%.MMA Capital (MMAC) +58%.Aptorum (APM) +37%.Creative Realities (CREX) +33%.Obalon Therapeutics (OBLN) +30%.Regional Health Properties (RHE) +24%.Taiwan Liposome (TLC) +21%.Virgin Galactic (SPCE) +19%.Verastem (VSTM) +18%.Veritiv (VRTV) +17%.Loser...

Aptorum Group (APM) gains 10% premarket after announcing progress in respect of its ongoing Phase I clinical trial for ALS-4 and Pre-IND preparation for SACT-1, a repurposed small molecule targeting neuroblastoma. ALS-4’s first-in-human Phase I trial is single and m...

Creative Realities (CREX) +34%.Virgin Galactic Holdings (SPCE) +19% after successful weekend space flight.Strongbridge Biopharma (SBBP) +15% after being acquired by Xeris Pharma.Jiuzi Holdings (JZXN) +9%.Aptorum Group Limited (APM) +9% on positive interim phase I clinical trial...

Regulatory News: Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) (“Aptorum Group”), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, today announced that Mr. Darren Lui, Presiden...

Alfi (ALF) +35%.SemiLEDs Corporation (LEDS) +19%.Protagenic Therapeutics (PTIX) +18%.Party City Holdco (PRTY) +12% on Q1 results.BioNTech SE (BNTX) +9% on Q1 results.Aptorum Group Limited (APM) +8%.VYNE Therapeutics (VYNE) +8%.Inovio Pharmaceuticals (INO) +8% on positive data f...

Aptorum Group (APM) has entered into an agreement with Exeltis to develop, manufacture and commercialize a novel preclinical candidate intended to target woman’s health and gynecological conditions.The deal will help develop a preclinical candidate for Aptorum in the European Unio...